NCT00005658View on ClinicalTrials.gov

Glycine to Treat Psychotic Disorders in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2000

Study Completion Date

January 31, 2002

Conditions
Psychotic DisorderSchizoaffecitve DisorderSchizophrenia
Interventions
DRUG

Glycine

Trial Locations (1)

20892

National Institute of Mental Health (NIMH), Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00005658 - Glycine to Treat Psychotic Disorders in Children | Biotech Hunter | Biotech Hunter